(NasdaqGM:EVER), Second Quarter Revenue Growth of 34% Year-Over-Year to $156.6 million Second Quarter Variable Marketing Dollars Increase 25% Year-Over-Year to $45.5 million Delivers Second Quarter Record Net Income of $14.7 million and Adjusted EBITDA of $22.0 million Announces $50.0 million Inaugural Share Repurchase Program CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: […]
EverQuote Announces Second Quarter 2025 Financial Results GlobeNewswire August 04, 2025 Second Quarter Revenue Growth of 34% Year-Over-Year to $156.6 million Second Quarter Variable Marketing Dollars Increase 25% Year-Over-Year to $45.5 million Delivers Second Quarter Record Net Income of $14.7 million and Adjusted EBITDA of $22.0 million Announces $50.0 million Inaugural Share Repurchase Program CAMBRIDGE,
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024
(NasdaqGM:SIBN), Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7% U.S. revenue of $46.4 million, representing growth of 22.8% Gross margin of 79.8%, representing an improvement of 80 basis points Net loss of $6.2 million, representing an improvement of 31.2% Positive adjusted
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven GlobeNewswire August 04, 2025 Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7% U.S. revenue of
(NasdaqGM:ARDX), Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative,
Ardelyx Announces Changes to the Executive Leadership Team GlobeNewswire August 04, 2025 Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical
Muralto, Switzerland, Aug. 04, 2025 (GLOBE NEWSWIRE) — METAVSHN LLC, a Swiss leader in advanced software platforms for Internet Service Providers (ISPs), has announced the launch of a new mobile virtual network operator (MVNO) brand, “HCAP Connect,” in collaboration with Ticinocom SA and in official partnership with the legendary Hockey Club Ambri Piotta (HCAP). Dario
GameAbove Sports continues to expand its influence in the city of Detroit GameAbove Sports, the ownership group behind the new BIG3 franchise Detroit Amplifiers (“Amps”) and title sponsor of the GameAbove Sports Bowl in December, is proud to announce a partnership with the Detroit Tigers. https://mma.prnewswire.com/media/2743786/GameAbove_sign_in_left_field_of_Comerica_Park_home_of_the_Detroit_Tigers.jpg GameAbove will show its support for one of the
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / August 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced multiple key milestones demonstrating the progression of the Company’s Biologics and Drug Delivery Portfolio including first commercial infusions in the United